Ampligen became the first drug ever approved for use in ME/CFS when ANMAT, Argentine’s FDA, approved the drug for use in severe ME/CFS patients. The approval should provide a clear pathway for Ampligen’s approval elsewhere. The U.S. is the odd man out in...
If you live in the U.S. where drugs typically cost 2-6 times more than elsewhere, drug bills can really add up. Buying drugs from international pharmacies can save U.S. consumers a lot of money – but is it safe? Health Rising takes a look in that issue in Buying...
Is newer better? Not according to Consumer Reports which, based on cost and effectiveness criteria, picked three generic drugs over FDA approved drugs for FM patients. Check out which drugs they favored and download the report at Consumer Reports Recommends Generics...
With a UK trial for Rituximab at least temporarily in doubt, let’s turn the focus to Ampligen – a drug that is potentially one trial away from being approved for ME/CFS. Ampligen is still the only drug that’s been able to move the needle on exercise...
She’s had chronic fatigue syndrome (ME/CFS) for twenty-eight years and has left no stone unturned in her attempts to get well. She’s traveled widely and seen some of the best ME/CFS doctors in the world. Despite being connected to the hilt in the ME/CFS,...
The National Pain Report recently released the results of its fibromyalgia survey examining treatment effectiveness and other questions. Almost 1,500 people participated. (Please note that the percentages in this table are different from those in the National Pain...
A BIG thanks to the 550 people whose $57K in donations made Health Rising's winter drive a success :)
Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News
Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities.